Strides Arcolab Q1 profits up 31%

Pharma company Strides Arcolab profits were up 31 per cent to Rs 91 crore for the first quarter of the current fiscal because of higher injectables sales. The company's revenues increased 30 per cent to Rs 547 crore (normalised excluding Ascent business). The company's earnings per share rose 30 per cent to Rs 15.43.